Extendicare Inc. announced a 52.2% increase in adjusted EBITDA to $44.2 million for Q1 2026, driven by organic growth in home health care and acquisitions including Closing the Gap and nine LTC homes. Revenue rose 25.3% to $374.7 million, supported by LTC funding increases and home health care volume growth. In April 2026, Extendicare completed a $570 million acquisition of CBI Home Health and issued $450 million in senior unsecured notes to refinance debt, positioning the company for further growth. The company also declared a 5% dividend increase and reported strong liquidity with $320.9 million cash on hand at quarter-end.
Leading Japanese companies, startups, and research institutions are developing specialized AI models using NVIDIA Nemotron open models to address Japan's unique language, industrial, and workforce challenges. These AI applications range from enterpri...
ARCpoint Inc. announced it will likely miss the July 29, 2026 deadline to file its annual financial statements and related reports due to a lack of funds to pay auditors. The company has applied for a Management Cease Trade Order (MCTO) and awaits ap...
The Rosen Law Firm is investigating potential securities claims against Putnam Investment Management, LLC, alleging that the company may have provided misleading business information to investors. Investors who purchased Putnam stock-based mutual fun...
Several stocks experienced significant declines today driven by company-specific events. SANUWAVE Health's shares dropped 39.21% despite strong revenue guidance, Twin Vee Powercats fell 30.95% amid a legal investigation, and Gorilla Technology declin...
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
